SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of May 18
 +0.18 / +0.43%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Pharma & Biotech ETFs Soar on Trump's Drug Plan
May 14 / Zacks.com - Paid Partner Content


1 month-0.02% 3 years-9.02%
3 months-2.59% 5 years+7.47%
1 year+3.46% Since inception+10.94%
Data through 05/19/2018

Quote Details

Previous close$42.14
Open day’s range42.03 – 42.39
Net asset value (NAV)42.35 (05/18/2018)
Daily volume101,052
Average volume (3 months)85,847
Data as of 8:00pm ET, 05/18/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+7.47%+14.29%
Expense Gross exp ratio0.35%1.29%
Risk 5 year sharpe ratio0.420.89
Net assets$334.0M$2.9B
Average market cap$7.6B$9.8B
Average P/E7.822.0
Dividend / Share--0.30%


FHLC Fidelity® MSCI Health Care Index ETF
XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MRK Merck4.78%
LLY Eli Lilly and Co4.56%
JAZZ Jazz Pharmaceuticals PLC4.47%
PFE Pfizer4.46%
ZTS Zoetis Inc4.42%
AGN Allergan4.38%
JNJ Johnson & Johnson4.24%
PRGO Perrigo Company PLC4.12%
MYL Mylan NV4.08%
CORT Corcept Therapeutics Inc3.84%